Atlas Trials

A Study to Assess the Safety, Tolerability and Pharmacokinetics of TCMCB07 in Single and Multiple Ascending Doses in Health Subjects

Clinical trial NCT05529849 · COMPLETED

Trial details

NCT number
NCT05529849
Sponsor
Endevica Bio
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cachexia
Start date
2022-07-12
Primary completion
2022-12-12
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.